Since the omicron variant, which originated in southern Africa, began popping up in various countries worldwide, the S&P 500 (SPX)…
Read More »S&P 500
Regeneron Pharmaceuticals’ (NYSE: REGN) monoclonal antibodies cocktail REGEN-COV (casirivimab and imdevimab), which received emergency use authorization from the FDA in…
Read More »Unlike the many other mundane weekly news recaps, the team at Wealthy VC has made it its mission to scour…
Read More »


